Epilepsy primary prevention

Revision as of 21:37, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Epilepsy Microchapters


Patient Information


Historical Perspective




Differentiating Epilepsy from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings


X Ray



Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epilepsy primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Epilepsy primary prevention

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epilepsy primary prevention

CDC on Epilepsy primary prevention

Epilepsy primary prevention in the news

Blogs on Epilepsy primary prevention

Directions to Hospitals Treating Epilepsy

Risk calculators and risk factors for Epilepsy primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.


Effective measures for the primary prevention of epilepsy include reducing the chance of possible epilepsy causes to happen including Head trauma, Hypoglycemia, Cerebral palsy, Electrolyte disturbances, fever, drug abuse and Vitamin deficiency and reduce the seizure triggers such as sleep deprivation, fever, light flashing, hyperventilation, alcohol, physical stress such as physical exercise or illness, psychological stress and depression.

Primary Prevention


  1. Annegers JF, Coan SP (October 2000). "The risks of epilepsy after traumatic brain injury". Seizure. 9 (7): 453–7. doi:10.1053/seiz.2000.0458. PMID 11034867.
  2. Dafoulas GE, Toulis KA, Mccorry D, Kumarendran B, Thomas GN, Willis BH, Gokhale K, Gkoutos G, Narendran P, Nirantharakumar K (February 2017). "Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study". Diabetologia. 60 (2): 258–261. doi:10.1007/s00125-016-4142-x. PMID 27796422.
  3. Diaconu G, Burlea M, Grigore I, Frasin M (2003). "[Epilepsy in different types of cerebral palsy]". Rev Med Chir Soc Med Nat Iasi (in Romanian). 107 (1): 136–9. PMID 14755984.
  4. Riggs JE (February 2002). "Neurologic manifestations of electrolyte disturbances". Neurol Clin. 20 (1): 227–39, vii. PMID 11754308.
  5. Shinnar S, Glauser TA (January 2002). "Febrile seizures". J. Child Neurol. 17 Suppl 1: S44–52. doi:10.1177/08830738020170010601. PMID 11918463.
  6. Cendes F, Andermann F, Carpenter S, Zatorre RJ, Cashman NR (January 1995). "Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans". Ann. Neurol. 37 (1): 123–6. doi:10.1002/ana.410370125. PMID 7818246.
  7. Keyser A, De Bruijn SF (1991). "Epileptic manifestations and vitamin B1 deficiency". Eur. Neurol. 31 (3): 121–5. doi:10.1159/000116660. PMID 2044623.
  8. Løyning Y (August 1993). "[Seizures and traffic risks]". Tidsskr. Nor. Laegeforen. (in Norwegian). 113 (18): 2231. PMID 8362382.
  9. Thapar A, Kerr M, Harold G (January 2009). "Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures". Epilepsy Behav. 14 (1): 134–40. doi:10.1016/j.yebeh.2008.09.004. PMID 18824131.
  10. LEVIN M (February 1950). "The pathogenesis of narcoleptic and epileptic seizures occurring under acute emotional stress". J. Nerv. Ment. Dis. 111 (2): 101–8. PMID 15409992.

Template:WH Template:WS